Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Registrati

Quotazioni in diretta

AURA Aura Biosciences Inc

7,13

-0,08 (-1,11%)

Ultimo aggiornamento: 16:57:09

Dati in Delay di 15 minuti

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

The sale reported represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.

Date of Notice

10/16/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Amy Elazzouzi, as Attorney-in-Fact

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Aura Biosciences (NASDAQ:AURA)
Storico
Da Feb 2025 a Mar 2025

Clicca qui per i Grafici di Aura Biosciences

Grafico Azioni Aura Biosciences (NASDAQ:AURA)
Storico
Da Mar 2024 a Mar 2025

Clicca qui per i Grafici di Aura Biosciences

Notizie Aura Biosciences Inc - AURA

Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress
Lunedì 3 Marzo 2025 (1 settimana fa) • GlobeNewswire Inc.

Aura Biosciences to Participate in Upcoming Investor Conferences
Martedì 25 Febbraio 2025 (2 settimane fa) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Mercoledì 19 Febbraio 2025 (3 settimane fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mercoledì 19 Febbraio 2025 (3 settimane fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mercoledì 19 Febbraio 2025 (3 settimane fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mercoledì 19 Febbraio 2025 (3 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 19 Febbraio 2025 (3 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 19 Febbraio 2025 (3 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 19 Febbraio 2025 (3 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 19 Febbraio 2025 (3 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 4 Febbraio 2025 (1 mese fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 4 Febbraio 2025 (1 mese fa) • Edgar (US Regulatory)

Più Aura Biosciences Inc Articoli Notizie

Invesco Trust II Invesco...

AMUNDI ETF GOVT BOND EUR...

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea